StockpollyBeta
Get App
Popularity #424
IONS · NASDAQ · Biotechnology

Ionis Pharmaceuticals (IONS)

Develops antisense medicines through owned launches and pharmaceutical partnerships.

$45.90
After hours+0.18 (+0.39%)
At close$45.72(+1.83%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue144325119225134227132452157203246268
Cost of revenue232414242833
Gross profit142321117221133223130448154195243265
285328267287281334277308315410361368
Research & development215257214222220245201217218280210217
707153656288769197130150150
General & administrative707153656288769197000
Other expenses000000000000
Operating income−143−6−150−66−149−111−147140−160−215−117−102
2370540−1632−1325−11
Interest income242626262629252524252520
Interest expense222222232323232322232222
Other non-operating income−23−24−27−23−26−25−21−5−52−5−426
Income before tax−141−3−143−66−144−107−147124−128−228−92−113
Income tax expense7600−4−300010−1
Net income from continuing operations−147−9−143−66−140−104−147124−129−229−93−112
Other adjustments00000000000−3
Net income−147−9−143−66−140−104−147124−129−229−93−115
EPS, basic−$1.03−$0.06−$0.98−$0.45−$0.95−$0.66−$0.93$0.78−$0.80−$1.41−$0.56−$0.69
EPS, diluted−$1.03−$0.06−$0.98−$0.45−$0.95−$0.66−$0.93$0.68−$0.80−$1.41−$0.56−$0.69
Weighted average shares, basic143144146146149158159159161162165165
Weighted average shares, diluted143144146146149158159182161162165165
EBITDA−11524−117−38−117−81−120150−1034,607−69−105
Depreciation & amortization6666555554,81773
EBIT−12018−122−43−123−86−125145−108−210−75−109